Clinical Trials

NCT06352229 | RECRUITING | NA
2327 participants

The Playful Learning in Infancy Program

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-26
Start Date:
2023-06-01
Completion:
2026-11-30
Conditions
  • Parent-Child Relations
  • Infant Development
Interventions
  • BEHAVIORAL
No Results Yet
NCT06327100 | RECRUITING | PHASE1/PHASE2
33 participants

Open Label Phase 1/2 Study of Tasquinimod in Patients With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (Post-PV MF), or Post-Essential Thrombocytosis Myelofibrosis (Post-ET MF)

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-26
Start Date:
2024-08-01
Completion:
2029-05-01
Conditions
  • Primary Myelofibrosis
  • Post-polycythemia Vera Myelofibrosis
  • Post-Essential Thrombocytosis Myelofibrosis
Interventions
  • DRUG
No Results Yet
NCT06324357 | RECRUITING | PHASE1/PHASE2
768 participants

Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-26
Start Date:
2024-06-03
Completion:
2029-01-08
Conditions
  • Metastatic Breast Cancer
  • Metastatic Gastric Adenocarcinoma
  • Gastroesophageal Junction Adenocarcinoma
  • Esophageal Adenocarcinoma
  • Colorectal Cancer
Interventions
  • DRUG
No Results Yet
NCT06299514 | RECRUITING | NA
600 participants

RAFT - Pace &Ablate

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-26
Start Date:
2024-04-25
Completion:
2028-12-31
Conditions
  • Atrial Fibrillation
  • Heart Failure
  • Pacemaker
  • Arrhythmia Atrial
Interventions
  • DEVICE
  • DRUG
No Results Yet
NCT06203600 | RECRUITING | PHASE2/PHASE3
224 participants

Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-26
Start Date:
2024-06-24
Completion:
2027-10-31
Conditions
  • Advanced Esophageal Adenocarcinoma
  • Advanced Gastric Adenocarcinoma
  • Advanced Gastroesophageal Junction Adenocarcinoma
  • Clinical Stage II Esophageal Adenocarcinoma AJCC v8
  • Clinical Stage III Esophageal Adenocarcinoma AJCC v8
  • Clinical Stage III Gastric Cancer AJCC v8
  • Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8
  • Clinical Stage IV Esophageal Adenocarcinoma AJCC v8
  • Clinical Stage IV Gastric Cancer AJCC v8
  • Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8
  • Metastatic Esophageal Adenocarcinoma
  • Metastatic Gastric Adenocarcinoma
  • Metastatic Gastroesophageal Junction Adenocarcinoma
  • Unresectable Esophageal Adenocarcinoma
  • Unresectable Gastric Adenocarcinoma
  • Unresectable Gastroesophageal Junction Adenocarcinoma
Interventions
  • PROCEDURE
  • BIOLOGICAL
  • DRUG
  • OTHER
No Results Yet
NCT06171685 | RECRUITING | PHASE2
300 participants

MMRC Horizon One: RRMM (MMRC-099)

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-26
Start Date:
2024-11-17
Completion:
2029-07-31
Conditions
  • Relapse Multiple Myeloma
  • Refractory Multiple Myeloma
Interventions
  • DRUG
No Results Yet
NCT06121232 | ACTIVE_NOT_RECRUITING | NA
24 participants
NCT06118554 | RECRUITING | NA
200 participants

3D Printing to Improve Nasal Irrigation Outcome

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-26
Start Date:
2021-11-01
Completion:
2027-06-26
Conditions
  • Chronic Rhinosinusitis With Nasal Polyps
  • Chronic Rhinosinusitis Without Nasal Polyps
Interventions
  • OTHER
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page